This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer Talks Dollar Tree (DLTR), Apple (AAPL), Coach (COH) and Facebook (FB) Stocks

NEW YORK (TheStreet) -- TheStreet's Jim Cramer answers Twitter (TWTR - Get Report) questions from the floor of the New York Stock Exchange, and the first one asks where Walmart (WMT - Get Report) stands in the wake of Family Dollar's (FDO - Get Report) deal with Dollar Tree (DLTR - Get Report).

Cramer calls Dollar Tree a "juggernaut" and tells Walmart to look out. The low end, which used to be Walmart's, is now Dollar Tree's and Cramer loves the store. He finds the prices are great and the selections are terrific and he prefers to go there over Walmart.

The next question asks if suppliers such as GT Advanced Technologies (GTAT) or service providers would benefit when the new iPhone comes out. Cramer responds with Skyworks (SWKS - Get Report) and notes Cirrus Logic (CRUS - Get Report) has come down, but he does not like to out-think these situations. If investors like Apple (AAPL - Get Report) off an iteration, then they should buy the stock.

Must Watch: Walmart, Family Dollar, Coach Top Cramer's Twitter Q&A

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

The next question deals with Coach (COH - Get Report), which reports earnings after the bell Monday. Cramer calls it "a very troubled institution" and he does not see any relevance there. He thinks there could be a bit of a bounce but says Michael Kors (KORS - Get Report) led the handbag business, and he has stayed away from this group ever since TheStreet's Herb Greenberg wrote Kors has been slowing. Therefore, he does not want to touch Coach.

In the biotech space, Cramer notes Celgene (CELG - Get Report) came down and he thought the quarter was excellent. He says CEO Bog Hugin was not promotional and this is a stock that goes up on announcements of new drugs. He likes this stock, but he also likes Biogen Idec (BIIB - Get Report) secondarily because Tecfidera is a maintenance drug that people do not have to take all their lives.

Cramer says Gilead's (GILD - Get Report) problem is new competition and insurers possibly balking, but he still likes the stock. Finally, Cramer says Regeneron (REGN - Get Report) must make its anti-cholesterol pill work because Eylea has taken the company as far as it could, but he thinks founder, president and CEO Leonard Schliefer will make it happen.

Lastly, a recent college graduate who has $10,000 in mutual funds and has started a 401k asks Cramer for a stock recommendation, and he does not hesitate to recommend Facebook (FB - Get Report). He thinks the stock will earn $3 in 2016 and could climb to $90 with a 30 multiple.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $126.44 -0.13%
BIIB $404.28 -0.28%
CELG $119.52 1.10%
COH $35.00 -0.37%
CRUS $33.66 -0.09%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs